ChemBriefUS House committee opens investigation into Merck, AbbVie China drug trials
A U.S. House committee launched an investigation into Merck and AbbVie over clinical trials in China, citing national security and ethical risks. Lawmakers require details on trial sites by July 17 am
reuters · 2026-06-30 03:02 UTC